TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31654567

Group type: EXPERIMENTAL
Intervention: Multidomain lifestyle program (psychoeducational material, physical activity tracker, nutrition tracker, audio-based meditations, health coaching)
Number of subjects: 559
Study: 29495607

Group type: EXPERIMENTAL
Intervention: Astaxanthin and Sesamin (AS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 27565061

Group type: EXPERIMENTAL
Intervention: Model building group (n=304)
Number of subjects: 604

Group type: COMPARATOR
Intervention: Test group (n=300)
Number of subjects: 604
Study: 24712335

Group type: EXPERIMENTAL
Intervention: Telephonic medication therapy management (MTM) intervention
Number of subjects: 895

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 895
Study: 23060426

Group type: EXPERIMENTAL
Intervention: Mipomersen 200 mg weekly subcutaneous
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study: 20420153

Group type: EXPERIMENTAL
Intervention: AWS with bougie
Number of subjects: 40

Group type: COMPARATOR
Intervention: AWS only
Number of subjects: 40
Study: 19127911

Group type: EXPERIMENTAL
Intervention: General regulation acupuncture and cupping therapy (warming needle moxibustion, plum-blossom needle, moving cupping, retaining the cup), thrice each week for 3 months
Number of subjects: 60
Study: 16519385

Group type: EXPERIMENTAL
Intervention: Latex agglutination test
Number of subjects: 287
Study: 12808177

Group type: EXPERIMENTAL
Intervention: Daytime dwell with 1100 ml/m2 icodextrin solution for one week (week 2)
Number of subjects: 8
Study: 10584283

Group type: EXPERIMENTAL
Intervention: Preseasonal short-term immunotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8738859

Group type: EXPERIMENTAL
Intervention: Magnesium infusion (8.12 mmol/day, group A, n = 81)
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Potassium infusion (10.49 mmol/day, group B, n = 77)
Number of subjects: 355

Group type: COMPARATOR
Intervention: 10% dextrose solution (group C, n = 87)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Placebo (2% dextrose solution, group D, n = 81)
Number of subjects: 355
Study: 1808632

Group type: EXPERIMENTAL
Intervention: Cyclopenthiazide 125 micrograms
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cyclopenthiazide 500 micrograms
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 6339293

Group type: EXPERIMENTAL
Intervention: Halometasone/triclosan cream
Number of subjects: 183

Group type: COMPARATOR
Intervention: Nerisona C cream
Number of subjects: 183
Study: 31390890

Group type: EXPERIMENTAL
Intervention: Peer counseling intervention to promote exclusive breastfeeding
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonexperimental estimates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tests for nonconsent bias in the benchmark RFE
Number of subjects: 0
Study: 29944044

Group type: EXPERIMENTAL
Intervention: Laser assisted hatching (LAH) for fresh embryos
Number of subjects: 240

Group type: COMPARATOR
Intervention: Non laser assisted hatching (non LAH) for fresh embryos
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Laser assisted hatching (LAH) for frozen embryos
Number of subjects: 240

Group type: COMPARATOR
Intervention: Non laser assisted hatching (non LAH) for frozen embryos
Number of subjects: 240
Study: 26312613

Group type: EXPERIMENTAL
Intervention: PRONTO training program
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 24
Study: 24549596

Group type: EXPERIMENTAL
Intervention: Metformin treatment (1,000 mg/day)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Obese PCOS women
Number of subjects: 178

Group type: COMPARATOR
Intervention: Lean PCOS women
Number of subjects: 178
Study: 22131086

Group type: EXPERIMENTAL
Intervention: Plyometric training for 14 weeks
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no plyometric training)
Number of subjects: 19
Study: 21049734

Group type: EXPERIMENTAL
Intervention: Topical formulation containing kojic acid, emblica extract, and glycolic acid
Number of subjects: 80

Group type: COMPARATOR
Intervention: Hydroquinone 4%
Number of subjects: 80
Study: 18201437

Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg daily)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg daily)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 16877479

Group type: EXPERIMENTAL
Intervention: Phototherapy with white curtains (n = 50)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Single phototherapy without curtains (n = 47)
Number of subjects: 97
Study: 12037372

Group type: EXPERIMENTAL
Intervention: Elmex toothpaste for unsupervised home use daily and Elmex gel for use once a week
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elmex toothpaste and placebo gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (usual oral care habits)
Number of subjects: 0
Study: 10208146

Group type: EXPERIMENTAL
Intervention: Writing about the most stressful event of their lives (n = 71; 39 asthma, 32 rheumatoid arthritis)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Writing about emotionally neutral topics (n = 41; 22 asthma, 19 rheumatoid arthritis)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Combined group of experimental patients (n = 70)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Combined group of control patients (n = 37)
Number of subjects: 112
Study: 7897151

Group type: EXPERIMENTAL
Intervention: Hydroxyzine 25 mg with cimetidine 600 mg every 12 hours for 10 days
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg with cimetidine 600 mg every 12 hours for 10 days
Number of subjects: 16

Group type: COMPARATOR
Intervention: Hydroxyzine alone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cetirizine alone
Number of subjects: 16
Study: 2650604

Group type: EXPERIMENTAL
Intervention: Rectal endosonography (ES)
Number of subjects: 0
Study: 334222

Group type: EXPERIMENTAL
Intervention: Nomifensine
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 31136331

Group type: EXPERIMENTAL
Intervention: ISB + Pecs II
Number of subjects: 40

Group type: COMPARATOR
Intervention: ISB
Number of subjects: 40
Study: 27984446

Group type: EXPERIMENTAL
Intervention: Primary wound closure
Number of subjects: 83
Study: 25425638

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV)
Number of subjects: 852

Group type: COMPARATOR
Intervention: Stavudine (d4T)
Number of subjects: 852

Group type: COMPARATOR
Intervention: Tenofovir (TDF)
Number of subjects: 852
Study: 23843020

Group type: COMPARATOR
Intervention: Conference calls (CC)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Individual calls (IC)
Number of subjects: 257
Study: 22138879

Group type: EXPERIMENTAL
Intervention: 8-week community-based exercise program (2 times per week) with home exercise program (HEP)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 19
Study: 19370449

Group type: EXPERIMENTAL
Intervention: SPIFA
Number of subjects: 336

Group type: COMPARATOR
Intervention: Modified SCID for Axis I disorders
Number of subjects: 336
Study: 17699310

Group type: EXPERIMENTAL
Intervention: Omacor 4-g dosage
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Omacor 8-g dosage
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Omacor (both dosages)
Number of subjects: 73
Study: 15059708

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with verteporfin
Number of subjects: 14
Study: 16006297

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (N = 25)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Low-fat diet (N = 22)
Number of subjects: 75
Study: 10591288

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention (n = 114)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Usual care (n = 114)
Number of subjects: 228
Study: 7534216

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA) insertion
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Tracheal intubation
Number of subjects: 46
Study: 1903847

Group type: EXPERIMENTAL
Intervention: rhGM-CSF
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 6165425

Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: BCNU
Number of subjects: 25

Group type: COMPARATOR
Intervention: Close observation
Number of subjects: 25
Study: 31085424

Group type: EXPERIMENTAL
Intervention: Meaningful social groups
Number of subjects: 151

Group type: COMPARATOR
Intervention: Arbitrary social groups
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Stressing the arbitrariness of the grouping dimension
Number of subjects: 151
Study: 28393757

Group type: EXPERIMENTAL
Intervention: LUCAS-2 mechanical chest compression
Number of subjects: 4471

Group type: COMPARATOR
Intervention: Manual chest compressions (control)
Number of subjects: 4471
Study: 26804646

Group type: EXPERIMENTAL
Intervention: JNJ‐40411813 (50mg to 150 mg b.i.d, flexibly dosed)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: JNJ‐40411813
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 24521953

Group type: EXPERIMENTAL
Intervention: Weight-based dosing (20 mg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard dosing (1 g)
Number of subjects: 20
Study: 22172554

Group type: EXPERIMENTAL
Intervention: Choline supplementation (1 g per day as choline bitartrate)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo supplement
Number of subjects: 42
Study: 20167991

Group type: EXPERIMENTAL
Intervention: efavirenz plus didanosine plus lamivudine (group 1)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: didanosine plus abacavir (group 3)
Number of subjects: 49

Group type: COMPARATOR
Intervention: tenofovir disoproxil fumarate plus lamivudine (group 2)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 49
Study: 16963184

Group type: COMPARATOR
Intervention: Placebo condition
Number of subjects: 0
Study: 15780099

Group type: EXPERIMENTAL
Intervention: Sirolimus combined with low-dose calcineurin inhibitors
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard immunosuppression regimen (Control)
Number of subjects: 16
Study: 11883835

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4) therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control solution
Number of subjects: 40
Study: 9687101

Group type: EXPERIMENTAL
Intervention: Amoxycillin (5, 7.5, or 10 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Amoxycillin (any dose)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil (2.5, 5, 7.5, or 10 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil (2.5, 5, 7.5, or 10 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Amoxycillin (oral doses)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil (oral doses)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil (oral doses)
Number of subjects: 12
Study: 8543963

Group type: EXPERIMENTAL
Intervention: Proportional hazards analysis with varying events per variable (EPV)
Number of subjects: 673

Group type: EXPERIMENTAL
Intervention: Monte Carlo simulations
Number of subjects: 673
Study: 2198932

Group type: EXPERIMENTAL
Intervention: Acetazolamide tablets
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sustet
Number of subjects: 20
Study: 30786336

Group type: EXPERIMENTAL
Intervention: TTMB
Number of subjects: 142

Group type: COMPARATOR
Intervention: TTSB
Number of subjects: 142
Study: 28886739

Group type: EXPERIMENTAL
Intervention: PEP Intervention practices (education, clinical audit and feedback, practice facilitation)
Number of subjects: 589

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: PEP Intervention practices
Number of subjects: 589

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 589
Study: 27185718

Group type: EXPERIMENTAL
Intervention: Extraglottic airway devices (EADs) with mask aperture bars (MABs)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Extraglottic airway devices (EADs) without mask aperture bars (MABs)
Number of subjects: 80
Study: 24555751

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Photosensitizer (PS)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 22
Study: 22383630

Group type: EXPERIMENTAL
Intervention: Oral pioglitazone (PIO) 15 mg once daily for 12 weeks
Number of subjects: 36
Study: 19796343

Group type: EXPERIMENTAL
Intervention: Group intervention (GRP)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Telephone counseling (TC)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 246
Study: 17315049

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 0
Study: 15030738

Group type: EXPERIMENTAL
Intervention: Docetaxel in combination with cisplatin (DP)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Other cisplatin-based regimens
Number of subjects: 3
Study: 12171669

Group type: EXPERIMENTAL
Intervention: Initial syphilis screening using rapid plasma reagin or Venereal Disease Research Laboratory tests, confirmed by fluorescent treponemal antibody absorption.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Routine syphilis testing after delivery.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recommendation for a second routine test for syphilis early in the third trimester.
Number of subjects: 0
Study: 10530094

Group type: EXPERIMENTAL
Intervention: 3D action with an additional pulsating movement
Number of subjects: 32

Group type: COMPARATOR
Intervention: D9 oscillating/rotating action
Number of subjects: 32
Study: 8078449

Group type: EXPERIMENTAL
Intervention: Nutrition support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nutrition therapy
Number of subjects: 0
Study: 2815968

Group type: EXPERIMENTAL
Intervention: Suckling mouse brain rabies vaccine with equine hyperimmune serum (40 IU per kg body weight)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Suckling mouse brain rabies vaccine without equine hyperimmune serum
Number of subjects: 50
Study: 16799

Group type: COMPARATOR
Intervention: Nefopam HCl + Placebo
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Nefopam HCl + Codeine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Nefopam HCl + Pentazocine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Nefopam HCl + Propoxyphene
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Nefopam HCl
Number of subjects: 45
Study: 31972826

Group type: EXPERIMENTAL
Intervention: High-load (HL) resistance exercise (5 repetitions at 85% 1RM)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Blood flow-restricted (BFR) resistance exercise (30 repetitions at 30% 1RM)
Number of subjects: 15
Study: 31613689

Group type: COMPARATOR
Intervention: Conventional Laparoscopic Appendectomy (CLA)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Single-Port Laparoscopic Appendectomy (SPLA)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Both approaches (CLA and SPLA)
Number of subjects: 147
Study: 28184045

Group type: EXPERIMENTAL
Intervention: Active group with inhaler labels (ACCa; THa)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group without inhaler labels (ACCc; THc)
Number of subjects: 95
Study: 25939894

Group type: EXPERIMENTAL
Intervention: Cilengitide 2000 mg 1×/week i.v. (CIL-once)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control (cetuximab plus platinum-based chemotherapy)
Number of subjects: 169
Study: 22735311

Group type: EXPERIMENTAL
Intervention: CAG with fibrin glue
Number of subjects: 20

Group type: COMPARATOR
Intervention: CAG with patients' own blood
Number of subjects: 20
Study: 21886035

Group type: EXPERIMENTAL
Intervention: Simulation video (SIM)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Control group (no further intervention)
Number of subjects: 239
Study: 18593517

Group type: EXPERIMENTAL
Intervention: Valsartan/HCTZ (160/12.5 mg, titrated to 160/25 mg after 2 weeks and to 320/25 mg after 4 weeks)
Number of subjects: 608

Group type: COMPARATOR
Intervention: Valsartan monotherapy (160 mg, titrated to 320 mg after 2 weeks and sham-titrated to 320 mg after 4 weeks)
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Valsartan/HCTZ
Number of subjects: 608

Group type: COMPARATOR
Intervention: Valsartan monotherapy
Number of subjects: 608
Study: 16295261

Group type: EXPERIMENTAL
Intervention: Participation in research aimed at determining treatment effectiveness
Number of subjects: 0

Group type: COMPARATOR
Intervention: Established treatments
Number of subjects: 0
Study: 12232450

Group type: EXPERIMENTAL
Intervention: Formoterol (Oxis) Turbuhaler plus Budesonide (Pulmicort) Turbuhaler
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Budesonide (Pulmicort) Turbuhaler alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Noncorticosteroid treatment (control group)
Number of subjects: 0
Study: 10406361

Group type: EXPERIMENTAL
Intervention: Behavioural intervention by an old-age psychiatry hospital outreach team, including seminars and weekly visits from a psychiatric nurse over 6 months.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 120
Study: 7752637

Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention
Number of subjects: 3977

Group type: COMPARATOR
Intervention: Control participants
Number of subjects: 3977

Group type: EXPERIMENTAL
Intervention: Participants identifying as former or recovering alcoholics
Number of subjects: 3977

Group type: EXPERIMENTAL
Intervention: Binge drinking
Number of subjects: 3977
Study: 1979494

Group type: EXPERIMENTAL
Intervention: Drug A (propyphenazone 250 mg, ethylmorphine 5 mg, caffeine 5 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Drug B (dipyrone 500 mg, diphenhydramine 12.5 mg, adiphenine 5 mg, ethyl aminobenzoate 2.5 mg)
Number of subjects: 10
Study: 375943

Group type: EXPERIMENTAL
Intervention: 1-phenylephrine hydrochloride gel
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 12
Study: 28960542

Group type: EXPERIMENTAL
Intervention: 18‐week supervised exercise programme
Number of subjects: 50
Study: 27614727

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 215

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 215
Study: 22968626

Group type: EXPERIMENTAL
Intervention: Toremifene
Number of subjects: 253

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 253
Study: 23521375

Group type: EXPERIMENTAL
Intervention: Short-course antenatal zidovudine (ZDV)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Single-dose nevirapine (sdNVP)
Number of subjects: 159
Study: 20687401

Group type: EXPERIMENTAL
Intervention: Child-and-parent group (N = 23)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Child-alone group (N = 19)
Number of subjects: 42
Study: 18691796

Group type: EXPERIMENTAL
Intervention: Audio tone guidance (low-pitched sound every 0.6 s for chest compression guidance and high-pitched sound every 10 deliveries for ventilation guidance at 6s intervals)
Number of subjects: 80

Group type: COMPARATOR
Intervention: No feedback (control group)
Number of subjects: 80
Study: 15757015

Group type: EXPERIMENTAL
Intervention: Alendronate 5 mg/d for 2 years and 10 mg/d thereafter
Number of subjects: 3737

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3737
Study: 12618160

Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg)
Number of subjects: 1008

Group type: COMPARATOR
Intervention: Continuous combined hormone replacement therapy (2 mg 17beta‐oestradiol and 1 mg norethisterone acetate)
Number of subjects: 1008
Study: 10693159

Group type: EXPERIMENTAL
Intervention: risperidone
Number of subjects: 56

Group type: COMPARATOR
Intervention: haloperidol
Number of subjects: 56
Study: 9350383

Group type: EXPERIMENTAL
Intervention: 20 mg oral zolmitriptan
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 2 mg oral ergotamine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combination of zolmitriptan and ergotamine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 8363027

Group type: EXPERIMENTAL
Intervention: Propofol (1.5 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Etomidate (0.3 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Midazolam (0.15 mg/kg)
Number of subjects: 60
Study: 3079695

Group type: EXPERIMENTAL
Intervention: Low-dose misoprostol
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: High-dose misoprostol
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 29717288

Group type: COMPARATOR
Intervention: Hyperbaric bupivacaine 5 mg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hyperbaric bupivacaine 5 mg plus dexmedetomidine 5 µg intrathecally
Number of subjects: 50
Study: 27294328

Group type: EXPERIMENTAL
Intervention: Running at 55%, 65%, and 75% maximal oxygen consumption for 30 minutes
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Recovery after exercise
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exercise (all intensities)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Recovery (after exercise)
Number of subjects: 10
Study: 24893325

Group type: EXPERIMENTAL
Intervention: Expert guided mentorship session (20 minutes)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (regardless of randomization)
Number of subjects: 50
Study: 22579428

Group type: EXPERIMENTAL
Intervention: Active acupressure
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Placebo acupressure
Number of subjects: 109

Group type: COMPARATOR
Intervention: Relaxation CD control
Number of subjects: 109
Study: 20215759

Group type: EXPERIMENTAL
Intervention: Acupuncture group 1 (LI 11)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Relaxation group (control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acupuncture groups (1 and 2)
Number of subjects: 60
Study: 18514303

Group type: EXPERIMENTAL
Intervention: gemcitabine plus axitinib (1000 mg/m² plus 5 mg twice daily)
Number of subjects: 103

Group type: COMPARATOR
Intervention: gemcitabine alone (1000 mg/m²)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: gemcitabine plus axitinib
Number of subjects: 103

Group type: COMPARATOR
Intervention: gemcitabine alone
Number of subjects: 103